Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Milliardenmarkt Multiple Sklerose: Neue Therapieform könnte alles verändern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0JKUU | ISIN: NO0010205966 | Ticker-Symbol: N1A
Frankfurt
02.09.25 | 21:49
1,805 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
NAVAMEDIC ASA Chart 1 Jahr
5-Tage-Chart
NAVAMEDIC ASA 5-Tage-Chart

Aktuelle News zur NAVAMEDIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoNavamedic ASA: Updated key information relating to the rights issue-
14.08.Navamedic Slips To Loss In Q2 -
14.08.Navamedic ASA: Financial report for the 2nd quarter and first half of 2025231OSLO, Norway, Aug. 14, 2025 /PRNewswire/ -- In the first half of 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of high-quality prescription, consumer health...
► Artikel lesen
14.08.Navamedic Q2 2025 presentation: Underlying growth amid strategic acquisitions3
13.08.Navamedic ASA: National approvals of Flexilev in OraFID granted across all Nordic countries233OSLO, Norway, Aug. 13, 2025 /PRNewswire/ -- Navamedic is pleased to announce that it has received final approval for the packaging material in national languages for Norway, Sweden and Denmark...
► Artikel lesen
13.08.Navamedic ASA: National approvals of Flexilev in OraFID granted across all Nordic countries.2
11.08.Navamedic ASA: Invitation to 2025 2nd quarter presentation1
NAVAMEDIC Aktie jetzt für 0€ handeln
16.07.Navamedic completes dne pharma acquisition1
15.07.Navamedic ASA: Closing of the transaction to acquire the business of dne pharma349OSLO, Norway, July 15, 2025 /PRNewswire/ -- Reference is made to the stock exchange announcement published by Navamedic ASA ("Navamedic" or the "Company", OSE ticker: "NAVA") on 23 June 2025...
► Artikel lesen
15.07.Navamedic ASA: Ex. subscription rights today-
14.07.Navamedic ASA - Minutes of Extraordinary General Meeting220OSLO, Norway, July 14, 2025 /PRNewswire/ -- The announced Extraordinary General Meeting of Navamedic ASA was held today at 13.00 CET. All items on the agenda were approved in accordance with...
► Artikel lesen
14.07.XFRA CAPITAL ADJUSTMENT INFORMATION - 14.07.2025256Das Instrument 8L8C US5303073051 LIBERTY BROADBAND C EQUITY wird cum Kapitalmassnahme gehandelt am 14.07.2025 und ex Kapitalmassnahme am 15.07.2025 The instrument 8L8C US5303073051 LIBERTY BROADBAND...
► Artikel lesen
11.07.Navamedic ASA: Mandatory notice of trade1
10.07.Navamedic ASA: Updated key information relating to the rights issue-
29.06.Navamedic ASA - Additional underwriting commitments in the Rights Issue1
27.06.Navamedic ASA: First approval of the medical device OraFID as primary package for a pharmaceutical product371OSLO, Norway, June 27, 2025 /PRNewswire/ -- Navamedic announces that the Swedish Medical Products Agency, acting as the Reference Member State, together with the Concerned Member States in...
► Artikel lesen
24.06.Navamedic signs agreement to acquire dne pharma2
24.06.Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS234OSLO, Norway, June 24, 2025 /PRNewswire/ -- Reference is made to the announcement made by Navamedic ASA (the "Company" or "Navamedic", and OSE ticker "NAVA") yesterday, on June 23, regarding...
► Artikel lesen
23.06.Navamedic ASA: Mandatory notice of trade-
23.06.Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in connection with a contemplated rights issue-
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1